[go: up one dir, main page]

BG104291A - 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use - Google Patents

3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use

Info

Publication number
BG104291A
BG104291A BG104291A BG10429100A BG104291A BG 104291 A BG104291 A BG 104291A BG 104291 A BG104291 A BG 104291A BG 10429100 A BG10429100 A BG 10429100A BG 104291 A BG104291 A BG 104291A
Authority
BG
Bulgaria
Prior art keywords
producing
same
derivatives
substituted
substituted tetrahydropyridopyrimidinone
Prior art date
Application number
BG104291A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wilfried Lubisch
Uta Dullweber
Dorothea Starck
Gerd Steiner
Alfred Bach
Franz Emling
Xavier Garcia-Ladona
Hans-Juergen Teschendorf
Karsten Wicke
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG104291A publication Critical patent/BG104291A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Structure And Mechanism Of Cameras (AREA)
BG104291A 1997-10-24 2000-04-03 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use BG104291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747063A DE19747063A1 (de) 1997-10-24 1997-10-24 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung
PCT/EP1998/006305 WO1999021857A1 (de) 1997-10-24 1998-10-05 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BG104291A true BG104291A (en) 2001-05-31

Family

ID=7846539

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104291A BG104291A (en) 1997-10-24 2000-04-03 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use

Country Status (27)

Country Link
US (1) US6414157B1 (xx)
EP (1) EP1025100B1 (xx)
JP (1) JP2001521035A (xx)
KR (1) KR20010015787A (xx)
CN (1) CN1277611A (xx)
AR (1) AR015466A1 (xx)
AT (1) ATE212346T1 (xx)
AU (1) AU748666B2 (xx)
BG (1) BG104291A (xx)
BR (1) BR9812970A (xx)
CA (1) CA2305258A1 (xx)
CO (1) CO4980862A1 (xx)
DE (2) DE19747063A1 (xx)
DK (1) DK1025100T3 (xx)
ES (1) ES2172222T3 (xx)
HR (1) HRP980554A2 (xx)
HU (1) HUP0004648A3 (xx)
ID (1) ID24633A (xx)
NO (1) NO20001934L (xx)
NZ (1) NZ503486A (xx)
PL (1) PL340034A1 (xx)
PT (1) PT1025100E (xx)
SK (1) SK3872000A3 (xx)
TR (1) TR200001102T2 (xx)
TW (1) TW432063B (xx)
WO (1) WO1999021857A1 (xx)
ZA (1) ZA989664B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
AU2003253186A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
JP4654035B2 (ja) 2002-11-05 2011-03-16 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 抗菌剤
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
DE102004020908A1 (de) 2004-04-28 2005-11-17 Grünenthal GmbH Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
AP2007004160A0 (en) * 2005-04-01 2007-10-31 Warner Lambert Co Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
CN101296914B (zh) * 2005-08-26 2012-07-18 盐野义制药株式会社 具有ppar激动活性的衍生物
CN102952129B (zh) * 2011-08-16 2015-09-23 上海师范大学 四氢吡啶并二氢嘧啶酮衍生物及其制备方法和应用
EP4232450A4 (en) 2020-10-21 2024-09-04 Aligos Therapeutics, Inc. BICYCLIC COMPOUNDS
WO2022266193A1 (en) 2021-06-18 2022-12-22 Aligos Therapeutics, Inc. Bicyclic compounds
CA3255324A1 (en) 2022-04-20 2023-10-26 Aligos Therapeutics, Inc. BICYCLE COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827149A (ja) * 1994-07-08 1996-01-30 Meiji Seika Kaisha Ltd ピリミジノン誘導体およびその塩

Also Published As

Publication number Publication date
WO1999021857A1 (de) 1999-05-06
CO4980862A1 (es) 2000-11-27
AR015466A1 (es) 2001-05-02
EP1025100A1 (de) 2000-08-09
ID24633A (id) 2000-07-27
KR20010015787A (ko) 2001-02-26
DE19747063A1 (de) 1999-04-29
ATE212346T1 (de) 2002-02-15
NO20001934D0 (no) 2000-04-13
EP1025100B1 (de) 2002-01-23
ZA989664B (en) 2000-04-25
DK1025100T3 (da) 2002-05-06
HRP980554A2 (en) 1999-08-31
HUP0004648A3 (en) 2001-11-28
ES2172222T3 (es) 2002-09-16
US6414157B1 (en) 2002-07-02
AU9748498A (en) 1999-05-17
SK3872000A3 (en) 2000-09-12
NZ503486A (en) 2001-04-27
JP2001521035A (ja) 2001-11-06
CN1277611A (zh) 2000-12-20
HUP0004648A2 (hu) 2001-05-28
PL340034A1 (en) 2001-01-15
TW432063B (en) 2001-05-01
TR200001102T2 (tr) 2000-08-21
CA2305258A1 (en) 1999-05-06
DE59802922D1 (de) 2002-03-14
BR9812970A (pt) 2000-08-08
PT1025100E (pt) 2002-07-31
NO20001934L (no) 2000-04-13
AU748666B2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
BG101194A (en) New heteroaryl oxazolidinons
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
IL130260A0 (en) 3-thiocarbamoylpyrazole derivatives as pesticides
PL343569A1 (en) New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
IL125223A0 (en) Novel substituted imidazole compounds
PL327934A1 (en) Novel substituted imidazole compounds
MY130489A (en) Substituted aryl 1, 4-pyrazine derivatives
PL289487A1 (en) Method of producing new aminophenol derivatives
BG102616A (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
AU9744298A (en) Substituted tetrahydronaphthaline and analogous compounds
BG104291A (en) 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
HU9700566D0 (en) Amino-alkyl- and acyl-amino-alkyl-ethers, process for producing them and their use as bradiquinine-receptor-antagonists
BG102770A (en) New derivatives of carboxylic acids, their preparation and application
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
BG102771A (en) Diarylmethylidenfuran derivatives, method for their preparation and utilization as medicamentous forms
MX9700813A (es) Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.
AU8631698A (en) A process for the preparation of tetraazamacrocycles
CA2298820A1 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
TR200000371T2 (tr) 3-İkame edilen 3,4,5,7,- tetrahidro-pirrolo [3',4':4,5] tieno[2,3-D] pirimidin türevleri, üretimi ve 5HT-antagonistleri olarak kullanımları.
ZA200005540B (en) New hydroxyindoles, their use as phosphodiestrase 4 inhibitors and method for producing same.